NCT00130026View on ClinicalTrials.gov

Caffeine in the Prevention of Post-operative Nausea and Vomiting

NACompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Postoperative Nausea and Vomiting
Interventions
DRUG

Caffeine

500 mg IV

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER

NCT00130026 - Caffeine in the Prevention of Post-operative Nausea and Vomiting | Biotech Hunter | Biotech Hunter